A Vip3A mutant protein with enhanced insecticidal activity and its application

By mutating specific amino acid sites in the Vip3A protein, its insecticidal activity against lepidopteran pests was improved, solving the problem of insufficient insecticidal activity of existing Vip3A proteins and achieving a highly efficient insecticidal effect against a variety of lepidopteran pests.

CN117659144BActive Publication Date: 2026-11-17HANGZHOU RUIFENG BIOTECH LIMITED
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202311579304.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-11-24
Publication Date
2026-11-17
Estimated Expiration
2043-11-24

AI Technical Summary

Technical Problem

The existing Vip3A protein has low insecticidal activity against some lepidopteran pests, and there is uncertainty in improving its insecticidal activity through mutation, making it difficult to predict the biological activity of the mutant protein against the target pests.

Method used

By making a single or double mutation at amino acid position 686 of the Vip3A protein, specifically by mutating amino acid position 686 to arginine and combining amino acid position 34 with a mutation from methionine to leucine, the insecticidal activity of Vip3A protein against lepidopteran pests can be improved.

Benefits of technology

It significantly improved the insecticidal activity against various lepidopteran pests such as fall armyworm, beet armyworm, and armyworm, with an increase of 1.1 to 14.5 times, delayed the development of pest resistance, and demonstrated broad-spectrum resistance to lepidopteran pests.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004567915390000051
    Figure BDA0004567915390000051
  • Figure BDA0004567915390000061
    Figure BDA0004567915390000061
  • Figure BDA0004567915390000071
    Figure BDA0004567915390000071
Patent Text Reader

Abstract

This invention discloses a Vip3A mutant protein with enhanced insecticidal activity and its application. The mutant protein is obtained by single or double mutation at positions 686 and 34 of the Vip3A protein amino acid sequence. The Vip3A protein refers to Vip3Ag and Vip3Af proteins, which possess insecticidal activity against lepidopteran pests. Enhancing the insecticidal activity of Vip3A protein against lepidopteran pests through amino acid site mutation has significant application value.
Need to check novelty before this filing date? Find Prior Art

Description

(I) Technical Field

[0001] This invention relates to Vip3A mutant proteins, their preparation methods and applications, and particularly to two types of improved Vip3A mutant proteins and their insecticidal activity, as well as the application of said Vip3A mutant proteins in the control of lepidopteran pests. (II) Background Technology

[0002] Pests cause billions of dollars in losses to global agricultural production annually. Pest control currently relies primarily on the use of chemical pesticides and the promotion of genetically modified (GM) crops. Chemical pesticide residues have adverse effects on human health and the environment. Developing GM insect-resistant crops containing insect-resistant genes using biotechnology can significantly reduce the use of chemical pesticides and effectively protect crops from pest damage. There are various insecticidal proteins, with the most widely used being insecticidal crystal proteins from Bacillus thuringiensis (Bt), such as Cry1A and Cry1F; and Bt vegetative-stage insecticidal proteins, such as Vip3 (Estruch, Warren et al. 1996; Adang, Crickmore et al. 2014). The application of Bt insecticidal proteins in GM plants has exceeded twenty years, and in 2017, the global area covered by insect-resistant GM crops exceeded 70 million hectares (ISAAA 2018). Insecticidal crystal proteins are the earliest discovered and most widely used Bt insecticidal proteins. Currently, the most commonly used insecticidal crystal proteins in commercially available insect-resistant genetically modified corn are Cry1Ab, Cry1Fa, and Cry2Ab. These insecticidal proteins have high insecticidal activity against some lepidopteran insects such as corn borer, cotton bollworm, diamondback moth, rice stem borer, rice leaf roller, and rice leaf roller.

[0003] Vip3 family proteins are evolutionarily unrelated to insecticidal crystal family proteins such as Cry1 or Cry2, and their insecticidal mechanisms are completely different (Chakroun, 2016). From an insecticidal spectrum perspective, Vip3A proteins exhibit high insecticidal activity against Lepidoptera noctuid moths (e.g., fall armyworm, cotton bollworm), but low or no activity against pyralid moths (e.g., corn borer) (Chakroun, Banyuls et al. 2016). The most diverse and commonly used Vip3Aa proteins (e.g., Vip3Aa1, Vip3Aa20, Vip3Aa45) have no insecticidal activity against pyralid moths (e.g., corn borer, rice stem borer). The insecticidal mechanism of Vip3A proteins is completely different from that of Cry proteins, and the two types of proteins also lack amino acid sequence homology, resulting in no cross-resistance between them. Vip3A protein and the insecticidal crystal protein Cry have different binding receptors in the insect midgut, and their toxicity mechanisms in insects differ, with no cross-resistance. Chakroun et al., summarizing literature, pointed out that Cry1A, Cry1Fa, and other proteins cannot interact with Vip3 protein through typical binding receptors in the insect midgut, indicating that the insecticidal crystal protein and Vip3 protein have different mechanisms of action in the insect midgut (Chakroun, Banyuls et al. 2016). Wang et al., through research on the fall armyworm, found that the binding receptor protein for Cry1F protein in the fall armyworm midgut is ABCC2, while the receptor for Vip3A protein is SR-C (Wang, Wang et al. 2019).

[0004] Generally, the modification of a protein's properties through mutation is highly uncertain. Modifying the insecticidal activity of Vip3A protein through mutation is also uncertain. The specific insecticidal mechanism of Vip3A protein is currently unclear, and its binding receptor on the surface of insect midgut cells is also unknown. The N-terminal sequence of Vip3A protein is highly conserved, while the C-terminal sequence exhibits diverse variations, each playing an important role in insecticidal activity. For example, Banyuls et al. found that mutating the 34th amino acid of Vip3Af protein from methionine to leucine can enhance its insecticidal activity against fall armyworm and cotton leafhopper (S. littoralis) (Banyuls, Quan et al. 2021). However, deletions, additions, or mutations in the C-terminal amino acid sequence of Vip3A protein can potentially reduce or eliminate its insecticidal activity, and the original protein's insecticidal spectrum may also change. For example, Zack et al. found that the insecticidal activity of the new protein obtained by exchanging the N-terminal (20kDa) sequences of Vip3Ab1 and Vip3Bc1 was completely lost (Zack, Sopko et al. 2017); C-terminal amino acid mutations (e.g., E483, W552, I699) also lead to a decrease or complete loss of the activity of Vip3A protein against target pests. Fang et al. obtained a chimeric protein Vip3AcAa with enhanced toxicity against fall armyworm and cotton bollworm through domain exchange (Fang, Xu et al. 2007); Sopko et al. chimeric Vip3Ab protein with Vip3Ai through sequence exchange, and the new protein Vip3Ab1-740 gained toxicity against armyworm while retaining toxicity against fall armyworm, cotton bollworm and soybean inchworm (Sopko, Narva et al. 2019). Currently, there are no reports of multi-site mutations in the Vip3A protein enhancing its insecticidal activity against lepidopteran pests. In general, due to the diversity of Vip3A's amino acid sequence and the uncertainty of its insecticidal mechanism, the biological activity of mutant Vip3A proteins against target pests cannot be predicted. Targeted modification of the Vip3A protein to obtain insecticidal proteins with higher activity requires creative discoveries.

[0005] In my country, the main lepidopteran insects that damage grain crops include the fall armyworm, beet armyworm, cotton bollworm, corn borer, rice stem borer, rice leaf roller, cotton bollworm, and armyworm. Due to differences in climate and environment, the types of lepidopteran pests affecting crops vary across different planting areas. For example, in northern corn-growing regions, the corn borer is predominant; in the Huang-Huai-Hai corn-growing region, the corn borer, armyworm, and fall armyworm are predominant; in northern and Xinjiang cotton-producing areas, the cotton bollworm is predominant; and in southern rice-growing regions, the rice stem borer, rice leaf roller, and other pests are common. Commonly used Vip3Aa proteins, such as Vip3Aa20, have high insecticidal activity against noctuid moths like the fall armyworm, but no activity against stem borers like the corn borer and rice stem borer, indicating a relatively narrow insecticidal spectrum. Chinese patent CN113793639A first disclosed the insecticidal activity of Vip3Af and Vip3Ag proteins against corn borers (including wild-type and mutant resistant corn borers), and proposed a method for managing corn borer resistance using Vip3A protein. Although Vip3Af and Vip3Ag exhibit relatively high insecticidal activity against fall armyworm and corn borer and have important application value, their insecticidal activity against beet armyworm, cotton bollworm, and armyworm is not high enough, potentially posing risks to resistance management in field applications. Therefore, improving the insecticidal activity of Vip3Af and Vip3Ag against these lepidopteran pests through protein modification engineering techniques (such as amino acid mutation) has significant application value. (III) Summary of the Invention

[0006] The purpose of this invention is to provide a Vip3A mutant protein with enhanced insecticidal activity and its application. This is achieved by mutating amino acid sites to improve the insecticidal activity of the Vip3A protein against lepidopteran pests. This invention provides two types of mutations to enhance the insecticidal activity of the Vip3A protein: first, mutating amino acid position 686 of the Vip3A protein to arginine; and second, simultaneously mutating amino acid position 686 to arginine and amino acid position 34 from methionine to leucine. This enhances the insecticidal activity of both Vip3Af and Vip3Ag proteins against certain lepidopteran pests, thus achieving the goal of improving the insecticidal activity of the Vip3A protein against some lepidopteran pests.

[0007] The technical solution adopted in this invention is:

[0008] This invention provides a Vip3A mutant protein for improving insecticidal activity. The mutant protein is obtained by making a single mutation or a double mutation at positions 686 and 34 of the amino acid sequence of the Vip3A protein. The Vip3A protein refers to the Vip3Ag protein and the Vip3Af protein, which have insecticidal activity against lepidopteran pests.

[0009] Furthermore, the single mutation involves mutating the 686th amino acid of the wild-type Vip3Af or Vip3Ag protein to arginine; the double mutation involves mutating the 34th amino acid of the Vip3Af or Vip3Ag mutant protein from methionine to leucine, while simultaneously mutating the 686th amino acid to arginine.

[0010] Further, the mutant protein is one of the following: (1) Vip3Ag protein with glycine at position 686 mutated to arginine (Vip3Ag-G686R, amino acid sequence as shown in SEQ ID NO:5, nucleotide sequence as shown in SEQ ID NO:6); (2) Vip3Ag protein with glycine at position 686 mutated to arginine and methionine at position 34 mutated to leucine (Vip3Ag-M34L / G686R, amino acid sequence as shown in SEQ ID NO:7, nucleotide sequence as shown in SEQ ID NO:8); (3) Vip3Af protein with threonine at position 686 mutated to arginine (Vip3Af-T686R, amino acid sequence as shown in SEQ ID NO:13, nucleotide sequence as shown in SEQ ID NO:14); (4) Vip3Af protein with threonine at position 686 mutated to arginine and methionine at position 34 mutated to leucine (Vip3Af-M34L / T686R, amino acid sequence as shown in SEQ ID NO:5, nucleotide sequence as shown in SEQ ID NO:6). As shown in NO:15, the nucleotide sequence is as shown in SEQ ID NO:16.

[0011] Furthermore, the amino acid sequence of the Vip3Ag protein is shown in SEQ ID NO:1, and the nucleotide sequence is shown in SEQ ID NO:2; the amino acid sequence of the Vip3Af protein is shown in SEQ ID NO:9, and the nucleotide sequence is shown in SEQ ID NO:10.

[0012] It should be noted that the Vip3A mutant protein described in this invention can be encoded by different nucleotide sequences. In particular, the frequency of use of different codons can vary in different species, and different nucleotide sequences can be used depending on the application scenario. For example, GC content is low in prokaryotic Escherichia coli, while it is high in plants such as rice and corn. Therefore, anything that can encode the Vip3A mutant protein disclosed in this invention, even if the nucleotide sequence is not included in this invention, should be considered part of this invention.

[0013] This invention also provides an expression cassette containing a gene encoding a Vip3A mutant protein. The gene expression cassette comprises a promoter, a coding gene, and a terminator. The promoter includes, but is not limited to, commonly used promoters in genetic engineering such as the maize ubiquitin promoter pZmUbi and the cauliflower mosaic virus 35S promoter pCaMV 35S, with pZmUbi (nucleotide sequence shown in SEQ ID NO:19) being the preferred promoter. The terminator includes, but is not limited to, the Agrobacterium nicotine synthase terminator tNOS and the cauliflower mosaic virus 35S RNA terminator tCaMV 35S, with tNOS (nucleotide sequence shown in SEQ ID NO:20) being the preferred terminator.

[0014] This invention provides a transformation vector for expressing the Vip3A mutant protein. The transformation vector contains the gene expression cassette described in this invention. The base vector of the transformation vector is a conventional plant genetic transformation vector, including but not limited to pCambia1300, pCambia1301, and pCambia2301. There are no restrictions on the relative order and insertion position of the gene expression cassette in the transformation vector; any transformation vector containing the gene expression cassette described in this invention should be considered part of this invention.

[0015] Furthermore, the transformation vector also includes a glyphosate selection marker gene G10-2 expression cassette. The G10-2 expression cassette is constructed by using the marker gene G10-epsps (SEQ ID NO:21) that can confer glyphosate resistance selection, and its expression is initiated by the yellow leaf curl virus promoter pCmYLCV (SEQ ID NO:22), and its expression is terminated by the original t35s terminator on pCambia1300.

[0016] This invention provides the application of the Vip3A mutant protein in the preparation of insect-resistant plants for controlling lepidopteran pests, wherein the insect-resistant plants are capable of expressing the Vip3A mutant protein of this invention. The insect-resistant plants of this invention can be obtained through plant genetic transformation methods. A transformation vector containing the gene expression cassette of this invention is introduced into plant cells using plant genetic transformation methods such as gene gun method, Agrobacterium-mediated transformation (maize (Ishida, Saito et al. 1996), soybean (Zeng, Vadnais et al. 2004), rice (Hiei, Komari et al. 1997)), etc., and integrated into the plant genome, enabling the plant cells to express the Vip3A mutant protein of this invention. The genetic transformation methods described herein are well known to those skilled in the art.

[0017] The lepidopteran pests described in this invention include at least one of the following pests: fall armyworm (Spodopterafrugiperda), beet armyworm (Spodoptera exigua), cotton bollworm (Spodoptera litura), armyworm (Mythimna separata), cotton bollworm (Helicoverpa armigera), cutworm (Agrotis ipsilon), corn borer (Ostrinia furnacalis), rice leaf roller (Cnaphalocrocis medinalis), rice stem borer (Chilosuppressalis), peach borer (Dichocrocis punctiferalis), bean pod borer (Maruca vitrata), diamondback moth (Plutella xylostella), gray-winged cutworm (Spodoptera mauritia), and two-spotted cutworm (Athetis lepigone).

[0018] The mutation method described in this invention alters the insecticidal activity of the Vip3A protein in an unpredictable manner. Compared to the wild-type protein, the Vip3Ag and Vip3Af mutant proteins described in this invention exhibit varying degrees of increased insecticidal activity against lepidopteran pests such as fall armyworm, beet armyworm, corn borer, cotton bollworm, armyworm, and rice stem borer. However, it is impossible to predict whether single-site mutant proteins and double-site mutant proteins will increase their insecticidal activity against the same pest, or the specific extent of such increase. The single-mutant Vip3Ag-G686R showed decreased activity against corn borer and rice stem borer, while the Vip3Ag-M34L / Vip3Af-M34L also showed decreased or absent activity against cotton bollworm, corn borer, and rice stem borer; however, the double-mutant Vip3Ag-M34L / G686R protein showed increased activity against these two pests. The single-mutant Vip3Af-T686R showed varying degrees of increased activity against all insects, but the double-mutant Vip3Af-M34L / T686R showed lower activity against the corn borer than Vip3Af-T686R, and was closer to the wild-type Vip3Af protein. Surprisingly, Vip3Af-M34L / T686R showed nearly 15 times more activity against the beet armyworm than wild-type Vip3Af, and nearly 13 times more activity against armyworms.

[0019] Compared with the prior art, the beneficial effects of the present invention are mainly reflected in:

[0020] (1) This invention proposes a novel method for improving the insecticidal activity of Vip3A protein. This invention utilizes amino acid mutation to obtain Vip3Ag / Vip3Af mutant proteins with higher activity against lepidopteran pests. The C-terminal region of Vip3A protein was previously considered closely related to protein activity, but its amino acid sequence is highly non-conserved, and its insecticidal molecular mechanism has not been fully elucidated. Arbitrary modifications often result in a decrease or loss of protein activity. The single-site mutation (G686R / T686R) and double-site mutation (M34LG686R / M34LT686R) involved in this invention can improve the insecticidal activity of Vip3A protein against lepidopteran pests such as the fall armyworm to varying degrees.

[0021] (2) The Vip3A mutant protein involved in this invention exhibits high insecticidal activity against lepidopteran pests. Many important lepidopteran pests, such as the fall armyworm, beet armyworm, and armyworm, are more sensitive to the mutant protein. Compared to the wild-type Vip3Ag / Vip3Af protein, the Vip3A mutant protein involved in this invention shows higher insecticidal activity against many important lepidopteran pests (e.g., fall armyworm, beet armyworm, armyworm, corn borer, cotton bollworm, rice stem borer, etc.), and the larvae of these pests are more sensitive to the mutant protein. Bioactivity assays show that the insecticidal activity of the mutant protein described in this invention is 1.1 to 14.5 times higher than that of the wild-type protein, providing important reference data for field application. The increased insecticidal activity plays an important role in delaying the development of pest resistance and can extend the lifespan of transgenic crops expressing the target protein.

[0022] (3) The Vip3A mutant protein involved in this invention has broad-spectrum anti-lepidopteran activity and does not exhibit any loss of insecticidal spectrum due to mutation. The Vip3Ag / Vip3Af mutant protein of this invention has broad-spectrum anti-lepidopteran pest characteristics and is toxic to a variety of important lepidopteran pests. In particular, it has higher insecticidal activity against important corn and rice lepidopteran pests such as fall armyworm, beet armyworm, corn borer, and rice stem borer, and is less likely to cause secondary pests to become major pests, showing great potential for production application. (IV) Detailed Implementation

[0023] The present invention will be further described below with reference to specific embodiments, but the scope of protection of the present invention is not limited thereto:

[0024] The molecular biology and biochemical methods used in the following embodiments of the present invention are all known techniques. These methods are found in *Current Protocols in Molecular Biology*, written by Ausubel and published by John Wiley and Sons, and *Molecular Cloning: A Laboratory Manual*, written by J. Sambrook et al. and published by Cold Spring Harbor Laboratory Press (2001), 3. rd Detailed explanations can be found in documents such as ED.

[0025] Example 1: Preparation of Bt recombinant protein

[0026] The encoding genes involved in this invention were all artificially synthesized by Shanghai Sangon Biotech Co., Ltd. The amino acid sequence of the wild-type Vip3Ag protein is shown in SEQ ID NO:1, and the nucleotide sequence is shown in SEQ ID NO:2; the amino acid sequence of Vip3Ag-M34L is shown in SEQ ID NO:3, and the nucleotide sequence is shown in SEQ ID NO:4; the amino acid sequence of Vip3Ag-G686R is shown in SEQ ID NO:5, and the nucleotide sequence is shown in SEQ ID NO:6; the amino acid sequence of Vip3Ag-M34L / G686R is shown in SEQ ID NO:7, and the nucleotide sequence is shown in SEQ ID NO:8. The amino acid sequence of the wild-type Vip3Af protein is shown in SEQ ID NO:9, and the nucleotide sequence is shown in SEQ ID NO:10; the amino acid sequence of Vip3Af-M34L is shown in SEQ ID NO:11, and the nucleotide sequence is shown in SEQ ID NO:12; the amino acid sequence of Vip3Af-T686R is shown in SEQ ID NO:13, and the nucleotide sequence is shown in SEQ ID NO:14; the amino acid sequence of Vip3Af-M34L / T686R is shown in SEQ ID NO:15, and the nucleotide sequence is shown in SEQ ID NO:16.

[0027] Recombinant proteins were expressed and prepared using the Escherichia coli pET expression system. The target gene was introduced into a pET expression vector, which was then transformed into a suitable expression strain. Under certain conditions, the expression of the target gene was induced to prepare the recombinant protein. In this embodiment, the preparation process was completely consistent for both wild-type and mutant proteins; the following description uses the Vip3Ag wild-type protein as an example.

[0028] The preparation process of Vip3Ag protein is as follows: The Vip3Ag gene was cloned into the expression vector pet28a (Novagen, 69015-3, USA) between the BamHI and SacI restriction endonuclease sites to obtain the recombinant plasmid pet28a-Vip3Ag; the recombinant plasmid was introduced into the Escherichia coli BL21(DE3) cell line by heat shock transformation and cultured overnight at 37°C on LB solid medium containing 50 mg / L kanamycin, and single-clone positive colonies were screened; the single-clone positive colonies were inoculated into LB liquid medium containing 50 mg / L kanamycin and cultured overnight at 37°C. After that, 0.2 ml of the bacterial culture was subcultured into an Erlenmeyer flask containing 200 ml of LB liquid medium containing 50 mg / L kanamycin and cultured at 37°C with shaking until OD. 600=0.6, then add IPTG (Isopropylβ-D-1-thiogalactopyranoside) to a final concentration of 0.5 mM, cool in a 4°C refrigerator for 10 min, then transfer to a 16°C constant temperature horizontal shaking incubator and culture at a constant speed of 100 rpm for 16 hours to induce the expression of recombinant protein; after expression, centrifuge the culture medium at 5000 rcf for 15 min, discard the supernatant culture medium, collect the cell pellet, and contaminate with 50 mL of 20 mM phosphate buffer (PBS, pH = 7.4). Cells were resuspended; the resuspension was then cooled thoroughly in ice water, and the cells were pulverized using an ultrasonic disruptor (Ningbo Xinzhi Biotechnology Co., Ltd., model JY92-IIN) (probe diameter 10mm, 650W, 50% of the machine display power for 15min, 3s working and 6s rest). After centrifugation at 12000rpm for 10min, the supernatant and precipitate were collected separately, and the band size of the target protein was verified by polyacrylamide gel electrophoresis (SDS-PAGE). Protein samples containing the correct target band were stored in a -80℃ freezer for later use. The recombinant Vip3Ag protein was present in the supernatant after sonication. The supernatant containing Vip3Ag protein was purified by His-tag (Qiagen, Ni-NTA superflow, Lot No. 160049084). The purification steps were performed according to the instructions of the reagent, as follows: (1) 1 ml of Ni-NTA resin was added to the column and allowed to stand until the layers separated; (2) the preservation solution was eluted and the resin was washed with 8 to 10 column volumes of Lysis Buffer until it was completely equilibrated; (3) the sample was added to the column, the column was sealed, and the column was gently shaken (or laid flat) and allowed to stand at room temperature (or 4°C, depending on the protein) for 30 min; (4) the column was placed on an iron stand and the supernatant was released at a flow rate of 1 ml / min; (5) the supernatant was washed with 5 column volumes of Wash buffer at a flow rate of 1 ml / min to remove impurities; (6) the supernatant was eluted with 5 column volumes of Elution buffer at a flow rate of 1 ml / min and the elution solution was preserved. Finally, the absorbance of A280 in the eluent was measured using a Mona EVA3100 detector (catalog number GD30101) to obtain the concentration of the target protein in the recombinant protein. The protein concentration was then adjusted to 2.5 mg / ml with Carbonate buffer (50 mM Na2CO3, pH=10) to obtain the Vip3Ag recombinant protein solution.

[0029] The protein purification process uses the following formulations: Lysis buffer: 20 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH adjusted to 8.0 with NaOH; Wash buffer: 20 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH adjusted to 8.0 with NaOH; Elution buffer: 20 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH adjusted to 8.0 with NaOH.

[0030] The LB liquid culture medium consists of: 10 g / L peptone, 5 g / L yeast extract, and 10 g / L sodium chloride, with double-distilled water as the solvent. It is sterilized at 120°C under high temperature and high pressure for 15 minutes. The LB solid culture medium is prepared by adding 15 g / L agar to the LB liquid culture medium, sterilizing it under high temperature and high pressure, and then inverting it into a sterilized petri dish to cool.

[0031] Vip3Ag-M34L, Vip3Ag-G686R, Vip3Ag-M34L / G686R, Vip3Af, Vip3Af-M34L, Vip3Af-T686R, and Vip3Af-M34L / T686R proteins were prepared using the same method and stored at -80°C for later use.

[0032] Example 2: Determination of the bioactivity of recombinant protein against lepidopteran insects

[0033] Experimental subjects: Insects within 2 hours of birth were selected as test insects. The test insects included fall armyworm, beet armyworm, cotton bollworm, corn borer, armyworm, and rice stem borer.

[0034] Treatment group: Preliminary experiments on the bioactivity of the recombinant protein prepared by the method in Example 1 were conducted (set at 1 ng / cm). 2 10ng / cm 2 100ng / cm 2 1000ng / cm 2 10000ng / cm 2 Five concentration groups were used. Based on the preliminary experimental results, the lowest concentration at which all the tested insects died was set as the upper limit concentration. Six concentration gradients were set up (concentration ranges are shown in Tables 1-6 below, diluted with PBS buffer at pH 7.4), and the concentration range in which the insects had a 50% lethality rate was determined. Eighty insects were tested in each concentration group.

[0035] Negative control group: The preparation method for the negative control is the same as in Example 1, except that the plasmid transformed into the Escherichia coli expression strain is an empty pet28a vector without any inserted DNA sequence.

[0036] Other protein control group: Vip3Aa20 protein (amino acid sequence SEQ ID NO:17) expressed by the pET system was used as the control protein. The preparation method was the same as in Example 1. The only difference was that the plasmid transformed into the E. coli expression strain was the pET28a plasmid containing the Vip3Aa20 gene (nucleotide sequence SEQ ID NO:18, synthesized by Shanghai Sangon Biotech Co., Ltd.).

[0037] Assay method: The median lethal concentration (LC50) of recombinant protein for insects was determined by the surface spreading method. 50 .

[0038] Cooked insect feed was spread evenly in 24-well culture plates (1.5 cm in diameter per well) and allowed to solidify. Twenty wells in each 24-well plate were randomly assigned as the experimental group, and four as the negative control group. 200 μL of recombinant protein was spread on the surface of the feed in each well of the experimental group, and 200 μL of negative control protein was spread on the surface of the feed in each well of the negative control group. After the entire plate was prepared, it was placed on a shaker at 120 rpm and shaken at room temperature (25-30℃) until the liquid dried. Two insects were introduced into each well, and the plates were sealed with breathable sealing film. The plates were then kept in a 28℃ incubator in the dark for 7 days. Insect mortality was recorded, and the corresponding median lethal concentration (LC50) was determined. 50 The results are shown in Table 7 below.

[0039] Table 1. Concentration gradient of recombinant proteins used to determine the bioactivity of newly hatched fall armyworm larvae (ng / cm³) 2 )

[0040]

[0041]

[0042] Table 2. Concentration gradient of recombinant proteins used to determine the bioactivity of newly hatched beet armyworm larvae (ng / cm³) 2 )

[0043] Recombinant proteins Concentration 1 Concentration 2 Concentration 3 Concentration 4 Concentration 5 Concentration 6 Vip3Aa20 2 5 25 50 250 500 Vip3Ag 2 5 25 50 250 500 Vip3Ag-M34L 2 5 25 50 250 500 Vip3Ag-G686R 2 5 25 50 250 500 Vip3Ag-M34L / G686R 2 5 25 50 250 500 Vip3Af 2 5 25 50 250 500 Vip3Af-M34L 2 5 25 50 250 500 Vip3Af-T686R 2 5 25 50 250 500 Vip3Af-M34L / T686R 0.5 2 5 25 100 250

[0044] Table 3. Concentration gradient of recombinant proteins used for bioactivity assays in newly hatched cotton bollworm larvae (ng / cm³) 2 )

[0045] Recombinant proteins Concentration 1 Concentration 2 Concentration 3 Concentration 4 Concentration 5 Concentration 6 Vip3Aa20 2 5 25 50 250 500 Vip3Ag 2 5 25 50 250 500 Vip3Ag-M34L 25 50 100 250 500 2000 Vip3Ag-G686R 2 5 25 50 250 500 Vip3Ag-M34L / G686R 2 5 25 50 250 500 Vip3Af 0.5 2 5 25 100 250 Vip3Af-M34L 0.5 2 5 25 100 250 Vip3Af-T686R 0.5 2 5 25 100 250 Vip3Af-M34L / T686R 0.5 2 5 25 100 250

[0046] Table 4. Concentration gradient of recombinant proteins used for bioactivity assays in newly hatched armyworm larvae (ng / cm³) 2 )

[0047] Recombinant proteins Concentration 1 Concentration 2 Concentration 3 Concentration 4 Concentration 5 Concentration 6 Vip3Aa20 50 100 250 500 2000 5000 Vip3Ag 25 50 100 250 500 2000 Vip3Ag-M34L 5 25 50 100 250 1000 Vip3Ag-G686R 5 25 50 100 250 1000 Vip3Ag-M34L / G686R 5 25 50 100 250 1000 Vip3Af 50 100 250 500 2000 5000 Vip3Af-M34L 5 25 50 100 250 1000 Vip3Af-T686R 5 25 50 100 250 1000 Vip3Af-M34L / T686R 5 25 50 100 250 1000

[0048] Table 5. Concentration gradient of recombinant proteins used for bioactivity assays in newly hatched corn borer larvae (ng / cm³) 2 )

[0049] Recombinant proteins Concentration 1 Concentration 2 Concentration 3 Concentration 4 Concentration 5 Concentration 6 Vip3Aa20 5000 5000 5000 5000 5000 5000 Vip3Ag 50 100 250 500 2000 5000 Vip3Ag-M34L 50 100 250 500 2000 5000 Vip3Ag-G686R 50 100 250 500 2000 5000 Vip3Ag-M34L / G686R 50 100 250 500 2000 5000 Vip3Af 25 50 100 250 500 2000 Vip3Af-M34L 5 25 50 100 250 1000 Vip3Af-T686R 5 25 50 100 250 1000 Vip3Af-M34L / T686R 5 25 50 100 250 1000

[0050] Table 6. Concentration gradient of recombinant proteins used for bioactivity assays in newly hatched larvae of the rice stem borer (ng / cm³) 2 )

[0051] Recombinant proteins Concentration 1 Concentration 2 Concentration 3 Concentration 4 Concentration 5 Concentration 6 Vip3Aa20 5000 5000 5000 5000 5000 5000 Vip3Ag 25 50 100 250 500 2000 Vip3Ag-M34L 50 100 250 500 2000 5000 Vip3Ag-G686R 50 100 250 500 2000 5000 Vip3Ag-M34L / G686R 25 50 100 250 500 2000 Vip3Af 25 50 100 250 500 2000 Vip3Af-M34L 50 100 250 500 2000 5000 Vip3Af-T686R 25 50 100 250 500 2000 Vip3Af-M34L / T686R 25 50 100 250 500 2000

[0052] The bioactivity of newly hatched larvae of Lepidoptera was determined using the experimental methods and concentration gradients described above. The results are shown in Table 7 below.

[0053] Table 7. Median lethal concentration (LC50) of recombinant proteins against newly hatched larvae of important lepidopteran pests. 50 (ng / cm 2 )

[0054]

[0055] The following conclusions can be drawn from the above results of the bioactivity assays on newly hatched larvae of Lepidoptera:

[0056] (1) The single-point mutation G686R / T686R can enhance the insecticidal activity of Vip3A protein (Vip3Ag / Vip3Af) against important lepidopteran pests. The insecticidal activity of Vip3Ag-G686R against fall armyworm, beet armyworm, cotton bollworm, and armyworm was increased by approximately 1.6 times, 1.9 times, 1.5 times, and 2.3 times, respectively, compared with wild-type Vip3Ag, while the insecticidal activity against corn borer and rice stem borer was decreased by 1.7 times and 4.2 times, respectively. The insecticidal activity of Vip3Af-T686R mutant protein against fall armyworm, corn borer, beet armyworm, cotton bollworm, armyworm, and rice stem borer was increased by approximately 2.8 times, 1.8 times, 2.4 times, 1.3 times, 2.1 times, and 2.8 times, respectively, compared with wild-type Vip3Af.

[0057] (2) The single point mutation M34L enhances the insecticidal activity of Vip3A protein (Vip3Ag / Vip3Af) against fall armyworm, beet armyworm, and armyworm, but reduces or eliminates its insecticidal activity against corn borer, cotton bollworm, and rice stem borer. Vip3Ag-M34L showed 8.3-fold, 1.3-fold, and 1.7-fold increased activity against fall armyworm, beet armyworm, and armyworm compared to wild-type Vip3Ag, respectively, but its activity against cotton bollworm decreased by 2.1-fold; and its activity against corn borer and rice stem borer was significantly reduced. 50 Greater than 2000ng / cm 2It almost lost its insecticidal activity. Vip3Af-M34L showed 11.5 times, 2.8 times, and 3.5 times higher activity against fall armyworm, beet armyworm, and armyworm than wild-type Vip3Ag, respectively, but its activity against cotton bollworm, corn borer, and rice stem borer decreased by 1.5 times, 1.8 times, and 1.9 times, respectively.

[0058] (3) The dual-site mutation (M34LG686R / M34LT686R) can enhance the insecticidal activity of Vip3A protein (Vip3Ag / Vip3Af) against important lepidopteran pests. The Vip3Ag-M34L / G686R mutant protein showed approximately 1.4 times, 1.1 times, 3.3 times, 1.2 times, 4.1 times, and 1.6 times higher insecticidal activity against fall armyworm, corn borer, beet armyworm, cotton bollworm, armyworm, and rice stem borer, respectively, compared to the wild-type Vip3Ag. The Vip3Af-M34L / T686R mutant protein showed approximately 2.2-fold, 14.4-fold, 1.05-fold, 12.5-fold, and 3.5-fold increased insecticidal activity against fall armyworm, beet armyworm, cotton bollworm, armyworm, and rice stem borer, respectively, compared to the wild-type Vip3Af protein; its insecticidal activity against corn borer was essentially the same as that of the wild-type Vip3Af protein.

[0059] (4) The mutation method described in this invention has uncertain effects on the insecticidal activity of Vip3A protein. Compared to wild-type protein, the Vip3Ag mutant protein and Vip3Af mutant protein described in this invention have varying degrees of increased insecticidal activity against lepidopteran pests such as fall armyworm, beet armyworm, corn borer, cotton bollworm, armyworm, and rice stem borer. However, it is impossible to predict whether the insecticidal activity of single-site mutant proteins and double-site mutant proteins against the same pest will be improved, or the specific degree of improvement. In this embodiment, the single-mutant Vip3Ag-G686R showed decreased activity against corn borer and rice stem borer, but the double-mutant Vip3Ag-M34L / G686R protein showed increased activity against these two pests. The single-mutant Vip3Af-T686R showed varying degrees of increased activity against all insects, but the double-mutant Vip3Af-M34L / T686R showed lower activity against the corn borer than Vip3Af-T686R, and was closer to the wild-type Vip3Af protein. Surprisingly, Vip3Af-M34L / T686R showed nearly 15 times more activity against the beet armyworm than wild-type Vip3Af, and nearly 13 times more activity against armyworms. This result suggests that the binding sites and receptor affinity mechanisms of the M34L and G686R / T686R mutations on the intestinal epithelial cells of lepidopteran pests may not be consistent. Furthermore, the toxicity of Vip3A protein on intestinal epithelial cells caused by single or double mutations of M34L or G686R / T686R in different insect species may not exhibit a synergistic effect. Specific analyses of specific insects are needed to identify the specific binding receptors and the changes in the affinity of the mutant protein for those receptors.

[0060] Example 3: Construction of the transformation vector

[0061] In this embodiment, the transformation vector is constructed based on the pCambia1300 vector (NCBI sequence number AF234296). Readers of this invention can achieve the same effect on other plant genetic transformation vectors, such as pCambia1301 and pCambia2301, using the method provided in this embodiment. The promoter used in the expression cassette of the insect-resistant gene can be any constitutive promoter, such as the cauliflower mosaic virus 35S promoter PCAMV35S, the maize ubiquitin promoter pZMUBI, etc., without any specific range limitation; the choice of terminator is not limited, for example, the commonly used Agrobacterium NOS terminator tNOS, the cauliflower mosaic virus 35S terminator T35S, etc., can all be used as terminators for the insect-resistant gene.

[0062] The coding genes involved in this invention were all artificially synthesized by Shanghai Sangon Biotech Co., Ltd. The nucleotide sequence of the coding gene Vip3Ag-G686R is SEQ ID NO:6, and the nucleotide sequence of the coding gene Vip3Ag-M34L / G686R is SEQ ID NO:8. The nucleotide sequence of the coding gene Vip3Af-T686R is SEQ ID NO:14, and the nucleotide sequence of the coding gene Vip3Af-M34L / T686R is SEQ ID NO:16. The promoter used in all cases is the maize ubiquitin promoter pZmUbi (nucleotide sequence shown in SEQ ID NO:19), and the terminator used in all cases is the Agrobacterium nicotine synthase terminator tNOS (nucleotide sequence shown in SEQ ID NO:20).

[0063] This embodiment uses the GR vector containing the Vip3Ag-G686R gene as an example for description. The other vectors (GD containing the Vip3Ag-M34L / G686R gene, FT containing the Vip3Af-T686R gene, and FD containing the Vip3Af-M34L / T686R gene) are constructed in the same way as the GR vector, differing only in the encoding of the Vip3A gene. The specific methods are as follows.

[0064] (1) Vector fragment: In order to use glyphosate to screen positive tissues during plant tissue culture, pCambia1300 was double-digested with restriction endonucleases KpnI and XhoI (purchased from Thermo Fisher Scientific) to remove the original hygromycin selection gene expression cassette in the 1300 vector. After incubation at 37°C for 1 h, the vector fragment 1300-FV with a size of about 6.8 kb was separated by electrophoresis and recovered.

[0065] (2) Insect-resistant gene Vip3Ag-G686R expression cassette: The maize ubiquitin promoter pZmUbi, the encoding gene Vip3Ag-G686R, and the Agrobacterium nicotine synthase terminator tNOS were linked to form an expression cassette. The total length of this expression cassette, Ubi-GR-nos, was 4.7 kb, and it was synthesized by Shanghai Sangon Biotech Co., Ltd. PCR amplification was performed using the primers listed in Table 8, and fragments of the corresponding sizes were recovered by agarose gel electrophoresis for subsequent vector construction.

[0066] (3) Glyphosate selection marker gene G10-2 expression cassette: The G10-2 expression cassette is an expression cassette constructed from the marker gene G10-epsps (SEQ ID NO:21) that confers glyphosate resistance. Its expression is initiated using the yellow leaf curl virus promoter pCmYLCV (SEQ ID NO:22) and terminated using the original t35s terminator from pCambia1300. The total length of this fragment cmp-g102 is 1.9 kb, synthesized by Shanghai Sangon Biotech Co., Ltd. PCR amplification was performed using the primers listed in Table 8, and fragments of the corresponding size were recovered by agarose gel electrophoresis for subsequent vector construction.

[0067] (4) Constructing transformation vectors: using the method of homologous recombination seamless cloning (e.g., Nanjing Novizan Biotechnology Co., Ltd.) The MultiS kit (product number C113-01) ligates the insect-resistant gene expression cassette and the G10-2 expression cassette into the HindIII and XhoI sites of the 1300-FV vector. Following the instructions, after mixing the seamless cloning reaction solution, incubate at 37°C for 30 minutes, then immediately place on ice to cool for at least 2 minutes.

[0068] Table 8. Primer sequences and corresponding amplified fragment lengths for PCR reactions.

[0069]

[0070] Amplification can be performed using a standard PCR reaction. For example, a high-fidelity enzyme 2×Phanta Max Master Mix (Novizan, catalog number P515-01) can be used, and the reaction system should be performed according to the instructions.

[0071] Table 9 PCR reaction procedure

[0072]

[0073] The concentration of the recovered PCR products was determined after agarose gel electrophoresis and gel extraction.

[0074] Table 10 Seamless Cloning Reaction Solution

[0075]

[0076] (5) Transformation of the transformation vector: Escherichia coli TG1 competent cells (Shanghai Angyu Biotechnology Co., Ltd., catalog number G6017) were thawed on ice, and the reaction solution after the seamless cloning reaction was added. The cells were then placed on ice for 25 min, followed by heat shock at 42°C for 45 s in a water bath, and then rapidly cooled on ice for 2 min. 1 ml of LB medium was added, and the cells were cultured at 37°C with shaking at 200 rpm for 1 h. The cells were then plated on LB solid medium containing 50 mg / L kanamycin and cultured overnight at 37°C. Single clones were then selected for sequencing identification.

[0077] (6) Identification and extraction of transformation vector: Select single-clone colonies from step (5) for sequencing identification, and store the correctly identified glycerol-containing clones in a -80℃ freezer. Extract the recombinant expression vector of the correctly identified clones and transform E. coli TG1 competent cells using the heat shock method. The operation steps are as follows: Place TG1 competent cells in ice to thaw (or place them in your palm or at room temperature for a moment, and quickly insert them into ice when the cells are in an ice-water mixed state), add 10 μL of recombinant expression vector, and gently mix by tapping the bottom of the EP tube with your hand, and let stand on ice for 25 minutes; heat shock in a 42℃ water bath for 45 seconds, quickly put them back on ice and let stand for 2 minutes; add 700 μL of antibiotic-free LB sterile medium to the centrifuge tube, mix well, and revive at 37℃, 200 rpm for 60 minutes; centrifuge at 5000 rpm for one minute to collect the bacteria, take about 100 μL of supernatant, gently pipette to resuspend the bacterial blocks and spread them on LB medium containing 50 mg / L kanamycin antibiotic; invert the plate and incubate overnight in a 37℃ incubator. Single colonies were picked and cultured overnight in LB liquid medium at 37°C with shaking at 220 rpm. Plasmids were extracted using the AxyPrep plasmid DNA miniaturization kit. The procedure is as follows: Take 1-4 ml of bacterial culture that has been cultured overnight in LB medium, centrifuge at 12,000 rpm for 1 min, and discard the supernatant; add 250 μL of Buffer S1 to suspend the bacterial pellet, ensuring uniform resuscitation without any small bacterial clumps; add 250 μL of Buffer S2, gently and thoroughly invert 4-6 times to mix thoroughly until the bacteria are fully lysed and a clear solution is formed; this step should not exceed 5 min; add 350 μL of Buffer S3, gently and thoroughly invert 6-8 times, and centrifuge at 12,000 rpm for 10 min; aspirate the supernatant from the previous step and transfer it to a preparation tube (placed in a 2 ml centrifuge tube), centrifuge at 12,000 rpm for 1 min, and discard the filtrate; place the preparation tube back into the centrifuge tube, add 500 μL of Buffer W1, centrifuge at 12,000 rpm for 1 min, and discard the filtrate; place the preparation tube back into the centrifuge tube, add 700 μL of Buffer S1... Centrifuge with Buffer W2 at 12,000 rpm for 1 min, discard the filtrate; wash again with 700 μL Buffer W2 using the same method, discard the filtrate; transfer the preparation tube back into a 2 ml centrifuge tube, centrifuge at 12,000 rpm for 1 min; transfer the preparation tube to a new 1.5 ml centrifuge tube, add 60-80 μL of Eluent or deionized water to the center of the membrane in the preparation tube, and let stand at room temperature for 1 min. Centrifuge at 12,000 rpm for 1 min. The plasmid of the recombinant expression vector RMhW1 is obtained, which is the transformation vector GR, and stored at -20℃ for later use.

[0078] Following the same steps as above, simply replace the insect-resistant gene with Vip3Ag-M34LG686R, Vip3Af-T686R, or Vip3Af-M34LT686R to construct the transformation vectors GD, FT, and FD, respectively.

[0079] It should be noted that this embodiment is merely an example of one method for constructing a transformation vector. Obviously, there is more than one type of transformation vector capable of achieving the intended purpose of this invention. Researchers in the art can easily construct transformation vectors using existing technologies. Researchers in the art can freely choose promoters and terminators according to the actual needs of specific research, as long as the expression of the Vip3A protein described in this invention can be achieved in cells. The use of the glyphosate selection marker gene G10-2 in this embodiment is merely to provide a screening method. Researchers in the art can replace the selection marker gene (e.g., neomycin phosphotransferase gene (nptⅡ), hygromycin phosphotransferase gene (hpt), chloramphenicol phosphotransferase gene (cat), streptomycin phosphotransferase gene (spt), Agrobacterium glyphosate-resistant epsps gene (CP4-epsps), glufosinate-resistant gene (pat), etc.) according to actual needs. The selection marker gene has no effect on the insecticidal activity of the Vip3A mutant protein. Therefore, any expression cassette or transformation vector containing the gene encoding the mutant protein described in this invention should be considered part of this invention.

[0080] Example 4: Transformation of Agrobacterium tumefaciens using recombinant plant transformation vector

[0081] The recombinant expression vector constructed in Example 3 was transformed into competent cells of Agrobacterium tumefaciens LBA4404 (Shanghai Angyu Biotechnology Co., Ltd., catalog number G6033) by electroporation (2200V) to prepare Agrobacterium tumefaciens strains for maize genetic transformation.

[0082] The method involved transforming the plasmid obtained in Example 3 into competent Agrobacterium LBA4404 cells via electroporation. The plasmid was then evenly spread onto YEP solid medium containing 50 mg / L kanamycin, 25 mg / L rifampin, and 15 mg / L tetracycline, and incubated at 28°C for 48–72 h. After single colonies emerged, a single colony was picked and transferred to YEP liquid medium containing 50 mg / L kanamycin, 25 mg / L rifampin, and 15 mg / L tetracycline. After incubation at 28°C for 48–72 h, an Agrobacterium culture medium containing the transformation vector (OD) was obtained. 600 =1.5~2.0), extract plasmids for sequencing and identification, and store correctly identified positive clones in a -80℃ freezer for later use.

[0083] YEP liquid culture medium consists of 10 g / L peptone, 10 g / L yeast extract, and 5 g / L NaCl, with water as the solvent, and is sterilized by high temperature and high pressure. If preparing solid culture medium, add 15 g / L agar.

[0084] Example 5: Obtaining Transgenic Maize

[0085] Maize genetic transformation was performed using Agrobacterium-mediated transformation, specifically following the method and culture medium formulation reported by Frame et al. (Plant Physiol, 2002, 129:13-22). Glyphosate was used as the screening reagent. The steps were as follows: Maize ears were collected 8-10 days after pollination, and immature embryos measuring 1.0-1.5 mm were collected. The Agrobacterium culture containing the transformation vector from Example 4 (OD2000) was then transformed. 600 ≈1.0) and immature embryos were co-cultured at 22℃ for 3-5 days. The cultured immature embryos were then transferred to callus induction medium containing a final concentration of 200 mg / L termethin antibiotic (Shanghai Yisheng Biotechnology Co., Ltd., catalog number 60230ES07), and cultured in the dark at 28℃ for 10-14 days to kill Agrobacterium. All callus tissues after induction culture were transferred to selection medium containing a final concentration of 2 mM glyphosate, and cultured in the dark at 28℃ for 2-3 weeks. The surviving embryogenic tissues were transferred to regeneration medium, cultured in the dark at 28℃ for 10-14 days, and then transferred to fresh regeneration medium, cultured under light at 26℃ for 10-14 days. Fully developed plantlets were selected and transferred to rooting medium, cultured under light at 26℃ until roots were fully developed, and then the rooted regenerated seedlings were transplanted to a greenhouse for growth and propagation.

[0086] Example 6: Determination of Vip3A mutant protein expression in transgenic crop transformants

[0087] The transgenic seedlings obtained in Example 5 were transferred to a greenhouse for continued growth after surviving. The expression level of the Vip3A mutant protein was determined when the maize reached the 5-6 leaf stage. 50 mg of fresh maize leaf tissue was collected, with three replicates from each leaf tissue. After grinding in liquid nitrogen, 500 μL of PBS buffer (pH 7.4, containing 1% protease inhibitor cocktail (MCE, catalog number HY-K0010)) was added. The mixture was thoroughly mixed and centrifuged at 12,000 rpm for 5 min. The supernatant was diluted 500-fold with PBS buffer and then analyzed by enzyme-linked immunosorbent assay (ELISA). The Vip3A ELISA quantitative kit (product number AA1641) from Shanghai Youlong Biotechnology Co., Ltd. was used for detection, following the product instructions. The negative control sample was non-transgenic maize leaf tissue at a similar growth stage, and the positive control sample was the positive protein sample provided in the ELISA kit. The expression level of Vip3A mutant protein in the T0 generation transgenic maize transformants ranged from 0.2 to 10.5 μg / g-fwt.

[0088] The expression level of Vip3A mutant protein can also be determined using the same method for other crop seedlings, such as transgenic rice, transgenic soybeans, and transgenic cotton. Simply replace the corn leaves in this example with the corresponding plant tissue (e.g., leaf tissue of transgenic rice).

[0089] Example 7: Determination of insect-resistant bioactivity of transgenic insect-resistant maize transformants

[0090] The transgenic plant transformants obtained by the method described in Example 5 were used to determine the expression level of insect-resistant proteins using the method described in Example 6. The plants were then transplanted to a greenhouse, and their bioactivity was measured after the plants had stabilized (corn entered the V6-8 leaf stage). The test insects in this example were fall armyworm, corn borer, beet armyworm, armyworm, cotton bollworm, and rice stem borer.

[0091] This embodiment uses newly hatched fall armyworm larvae as an example to describe the bioassay method. Other insects can be tested using the same method, simply by replacing the fall armyworm larvae with the corresponding newly hatched larvae. Take 5-6 cm of fresh plant leaf tissue and place it in a 7.5 cm diameter petri dish. Place a piece of moistened filter paper on top, and inoculate 10 newly hatched fall armyworm larvae (within 2 hours). Cover the dish and seal it with sealing film to prevent larvae escape. Five replicate treatment groups are set up for each transformant. Non-transgenic plants at the same growth stage serve as negative controls. After 5 days, the number of surviving larvae in each experimental group is counted, and the larval mortality rate is calculated. The mortality rate data is then analyzed.

[0092] In this embodiment, the bioactivity of each transformant that survived in the greenhouse was measured, and the mortality rate of the tested insects was recorded. Based on the expression levels of each transformant, the survival status of the tested insects, and the damage to the leaf tissues observed in the bioassay results, we categorized the maize transformants. The first category consisted of transformants with low expression levels of insect-resistant proteins. In these transformants, some tested insects survived, but not all died, and feeding holes were observed in the leaf tissues. The expression levels of these transformants were mostly between 0.2 and 2.0 μg / g-fwt. The second category consisted of transformants with moderate expression levels of insect-resistant proteins. In these transformants, almost all tested insects died, with only a few surviving (possibly due to cannibalism), and no obvious signs of feeding were observed in the leaf tissues. The expression levels of these transformants were mostly between 2.0 and 5.0 μg / g-fwt. The third category consisted of transformants with high expression levels of insect-resistant proteins. In these transformants, all tested insects died, and no signs of feeding were observed in the leaf tissues. The expression levels of these transformants were all greater than 5.0 μg / g-fwt. We divided the transformants into three categories based on the expression level of Vip3A protein, and counted the average mortality rate of the test insects in each category. The results are shown in Tables 11-14.

[0093] Table 11. Average mortality rate of lepidopteran pests after feeding on the GR transformant expressing Vip3Ag-G686R protein.

[0094]

[0095] Table 12. Average mortality rate of lepidopteran pests after feeding on GD-transformed organisms expressing Vip3Ag-M34LG686R protein.

[0096]

[0097] Table 13. Average mortality rate of lepidopteran pests after FT following feeding on transformants expressing Vip3Af-T686R protein.

[0098]

[0099] Table 14. Average mortality rate of lepidopteran pests after feed on transformants expressing Vip3Af-M34LT686R protein followed by FD.

[0100]

[0101] Finally, the above examples are merely some embodiments of the present invention. Obviously, the present invention is not limited to the above embodiments and can have many extensions and expansions. For example, researchers in the art can use genetic transformation methods to express the Vip3A mutant protein described in this invention in crops such as soybeans, cotton, rapeseed, cowpeas, and sunflowers to achieve the purpose of improving insecticidal activity against lepidopteran pests. The mutant protein described in this invention can be used to prepare transgenic insect-resistant plants or to prepare novel insecticides for controlling lepidopteran pests. All extensions that can be directly derived or conceived by those skilled in the art from the content disclosed in this invention should be considered within the scope of protection of this invention.

Claims

1. A Vip3A mutant protein for enhancing insecticidal activity, characterized in that, The mutant protein is obtained by mutating threonine at position 686 of the Vip3Af protein to arginine, or by mutating threonine at position 686 to arginine and methionine at position 34 to leucine; the amino acid sequence of the Vip3Af protein is shown in SEQ ID NO:

9.

2. An expression cassette comprising the gene encoding the Vip3A mutant protein of claim 1.

3. A transformation vector for expressing the Vip3A mutant protein of claim 1.

4. The application of the Vip3A mutant protein of claim 1 in the preparation of insect-resistant plants for controlling lepidopteran pests, characterized in that, The Lepidoptera pests mentioned are as follows: fall armyworm, beet armyworm, armyworm, cotton bollworm, corn borer, and rice stem borer.

Citation Information

Patent Citations

  • Method for managing resistance of ostrinia nubilalis to Bt insecticidal protein

    CN113793639A

  • Truncated Vip3Af protein and application thereof

    CN119638805A